Literature DB >> 21930127

Long isoform of ErbB3 binding protein, p48, mediates protein kinase B/Akt-dependent HDM2 stabilization and nuclear localization.

Chung Kwon Kim1, Sang Bae Lee, Truong L X Nguyen, Kyung-Hoon Lee, Sung Hee Um, Jihoe Kim, Jee-Yin Ahn.   

Abstract

p48 is a long isoform of the ErbB3 binding protein that has oncogenic functions including promotion of carcinogenesis and induction of malignant transformation through negative regulation of tumor suppressor p53. Here, we show that high level of p48 protein expression leads to enhance HDM2 phosphorylation by Akt and inhibits the self-ubiquitination of HDM2 by up-regulation of Akt activity, thereby promoting its protein stability. Moreover, p48 expression leads to accumulated nuclear localization of HDM2, whereas p48 depletion disturbs its nuclear localization. Hence, higher expression of p48 in cancer cells reduces p53 levels through modulation of HDM2 nuclear localization and protein stability via regulation of its Akt-mediated phosphorylation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930127     DOI: 10.1016/j.yexcr.2011.08.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Roles of ErbB3-binding protein 1 (EBP1) in embryonic development and gene-silencing control.

Authors:  Hyo Rim Ko; Inwoo Hwang; Eun-Ju Jin; Taegwan Yun; Dongryeol Ryu; Jong-Sun Kang; Kye Won Park; Joo-Ho Shin; Sung-Woo Cho; Kyung-Hoon Lee; Keqiang Ye; Jee-Yin Ahn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-20       Impact factor: 11.205

2.  HIV-1 viral protein R downregulates Ebp1 and stabilizes p53 in glioblastoma U87MG cells.

Authors:  S Zhang; B Zhang; X Xu; L Wang; X Feng; Q Wang; H Huang; J Wu; P Li; J Wang
Journal:  Clin Transl Oncol       Date:  2013-07-05       Impact factor: 3.405

3.  Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1.

Authors:  Le Xuan Truong Nguyen; Yunqin Lee; Lenore Urbani; Paul J Utz; Anne W Hamburger; John B Sunwoo; Beverly S Mitchell
Journal:  Blood       Date:  2015-02-17       Impact factor: 22.113

4.  High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).

Authors:  Chen Gong; Yixin Zhang; Yinji Chen; Haifeng Zhang; Xiaorong Liu; Huaqing Xue; Li Ji; Liang Wang; Linlin Yang; Guoxiong Zhou; Chunhua Wan
Journal:  Tumour Biol       Date:  2015-06-19

5.  Dysregulation of Epigenetic Control Contributes to Schizophrenia-Like Behavior in Ebp1+/- Mice.

Authors:  Inwoo Hwang; Jee-Yin Ahn
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

Review 6.  A structural view of PA2G4 isoforms with opposing functions in cancer.

Authors:  Brendan W Stevenson; Michael A Gorman; Jessica Koach; Belamy B Cheung; Glenn M Marshall; Michael W Parker; Jessica K Holien
Journal:  J Biol Chem       Date:  2020-09-20       Impact factor: 5.157

7.  EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.

Authors:  Laura Pisapia; Pasquale Barba; Angela Cortese; Valeria Cicatiello; Franco Morelli; Giovanna Del Pozzo
Journal:  Int J Oncol       Date:  2015-06-16       Impact factor: 5.650

8.  P42 Ebp1 regulates the proteasomal degradation of the p85 regulatory subunit of PI3K by recruiting a chaperone-E3 ligase complex HSP70/CHIP.

Authors:  H R Ko; C K Kim; S B Lee; J Song; K-H Lee; K K Kim; K W Park; S-W Cho; J-Y Ahn
Journal:  Cell Death Dis       Date:  2014-03-20       Impact factor: 8.469

9.  Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses.

Authors:  Yasuko Kitagishi; Mayumi Kobayashi; Kanae Kikuta; Satoru Matsuda
Journal:  Depress Res Treat       Date:  2012-12-18

10.  P42 Ebp1 functions as a tumor suppressor in non-small cell lung cancer.

Authors:  Hyo Rim Ko; Truong Lx Nguyen; Chung Kwon Kim; Youngbin Park; Kyung-Hoon Lee; Jee-Yin Ahn
Journal:  BMB Rep       Date:  2015-03       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.